This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dawn, B. Articles by Bolli, R. Search for Related Content PubMed PubMed Citation Articles by Dawn, B. Articles by Bolli, R. Related Collections Related Article

(Circulation Research. 2005;97:1080.)
© 2005 American Heart Association, Inc.

Editorials

Cardiac Progenitor Cells

The Revolution Continues

Buddhadeb Dawn, Roberto Bolli

From the Institute of Molecular Cardiology, University of Louisville, Ky.

Correspondence to Roberto Bolli, MD, Division of Cardiology, University of Louisville, Louisville, KY 40292. E-mail rbolli@louisville.edu

See related article, pages 1090–1092

Key Words: cardiac stem cells • myocardial reconstitution • cardiac primitive cells • bone marrow

An extract of the first 250 words of the full text is provided, because this article has no abstract.

In the last few years we have witnessed one of most extraordinary revolutions in cardiovascular medicine, namely, an explosion of basic and clinical studies that support the notion that the diseased heart can be repaired by administration of stem cells, resulting in formation of functional new myocytes and vessels. Although the mechanism by which cell therapy improves cardiac function and anatomy remains uncertain, translation of basic findings to the clinical setting is proceeding at a feverish pace.¹ A multitude of small, mostly nonrandomized clinical studies have reported improvement in cardiac perfusion and function after therapy with various cell types in patients with acute myocardial infarction or chronic ischemic cardiomyopathy.¹ Larger, randomized, double-blinded studies will be reported soon; if they confirm the salubrious effects of cell-based therapies observed in the initial trials, our management of acute myocardial infarction and heart failure will change dramatically.

One of the most important and unresolved issues in this scenario is the identity of the ideal cell for myocardial reconstitution. Although most of the clinical studies reported to date have used bone marrow– or skeletal muscle–derived cells, a host of other cells are being investigated in the experimental laboratory. Among these, resident cardiac stem cells (CSCs), discovered by Anversa’s group in 2003,² hold great promise. In their initial report,² Beltrami et al identified a lin–/c-kit+ population of primitive cells that can be clonally expanded, differentiates into cardiac myocytes, smooth muscle cells, and endothelial cells in vitro, and is able to reconstitute infarcted myocardium in vivo. It . . . [Full Text of this Article]

Related Article:

Restoration of Cardiac Progenitor Cells After Myocardial Infarction by Self-Proliferation and Selective Homing of Bone Marrow–Derived Stem Cells

Frédéric Mouquet, Otmar Pfister, Mohit Jain, Angelos Oikonomopoulos, Soeun Ngoy, Ross Summer, Alan Fine, and Ronglih Liao
Circ. Res. 2005 97: 1090-1092. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

				Y. L. Tang, W. Zhu, M. Cheng, L. Chen, J. Zhang, T. Sun, R. Kishore, M. I. Phillips, D. W. Losordo, and G. Qin Hypoxic Preconditioning Enhances the Benefit of Cardiac Progenitor Cell Therapy for Treatment of Myocardial Infarction by Inducing CXCR4 Expression Circ. Res., May 22, 2009; 104(10): 1209 - 1216. [Abstract] [Full Text] [PDF]

				J. S. Forrester, A. J. White, S. Matsushita, T. Chakravarty, and R. R. Makkar New Paradigms of Myocardial Regeneration Post-Infarction: Tissue Preservation, Cell Environment, and Pluripotent Cell Sources J. Am. Coll. Cardiol. Intv., January 1, 2009; 2(1): 1 - 8. [Abstract] [Full Text] [PDF]

				G. E. Hannigan, J. G. Coles, and S. Dedhar Integrin-Linked Kinase at the Heart of Cardiac Contractility, Repair, and Disease Circ. Res., May 25, 2007; 100(10): 1408 - 1414. [Abstract] [Full Text] [PDF]

				D. E. Atsma, S. L.M.A. Beeres, and M. J. Schalij Reply J. Am. Coll. Cardiol., July 4, 2006; 48(1): 220 - 220. [Full Text] [PDF]